US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust SMID Growth Strength ETF

29.30

-0.5048-1.69%

Post-market: 29.17-0.1302-0.44%16:10 EDT

Volume:1.14K

Turnover:33.18K

Market Cap:27.84M

PE:- -

High:29.30

Open:29.23

Low:29.17

Close:29.81

52wk High:31.95

52wk Low:24.39

Shares:950.00K

Float Shares:950.00K

Volume Ratio:0.59

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET

Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025

Dimerix's Drug Candidate to Treat Kidney Disease Receives Orphan Drug Designation in Japan

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FSGS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FSGS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FSGS\",,,,,undefined,":{"symbol":"FSGS","market":"US","secType":"STK","nameCN":"First Trust SMID Growth Strength ETF","latestPrice":29.3002,"timestamp":1773432000000,"preClose":29.805,"halted":0,"volume":1137,"hourTrading":{"tag":"盘后","latestPrice":29.17,"preClose":29.3002,"latestTime":"16:10 EDT","volume":6,"amount":175.8012,"timestamp":1773432604685,"change":-0.1302,"changeRate":-0.004444,"amplitude":0},"delay":0,"changeRate":-0.016936755577923148,"floatShares":950002,"shares":950002,"eps":0,"marketStatus":"Market Closed","change":-0.5048,"latestTime":"03-13 16:00:00 EDT","open":29.23,"high":29.3002,"low":29.17,"amount":33184.4322,"amplitude":0.004368,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":29.805,"sharesOutstanding":950002,"nav":29.26,"aum":27797058.52,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":29.17,"preClose":29.3002,"latestTime":"16:10 EDT","volume":6,"amount":175.8012,"timestamp":1773432604685,"change":-0.1302,"changeRate":-0.004444,"amplitude":0},"volumeRatio":0.5909563808858261},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FSGS\",,,,,undefined,":{"symbol":"FSGS","floatShares":950002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5909563808858261,"shares":950002,"dividePrice":0,"high":29.3002,"amplitude":0.004368,"preClose":29.805,"low":29.17,"week52Low":24.39,"pbRate":"--","week52High":31.95,"institutionHeld":0,"latestPrice":29.3002,"eps":0,"divideRate":0,"volume":1137,"delay":0,"ttmEps":0,"open":29.23,"prevYearClose":30.4325,"prevWeekClose":30.1209,"prevMonthClose":30.6815,"prevQuarterClose":30.4325,"fiveDayClose":30.1209,"twentyDayClose":30.08,"sixtyDayClose":30.9128},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FSGS\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FSGS","amount":0.3931,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"FIRST TRUST EXCHANGE-TRADED FUND VI FIRST TRUST SMID GROWTH STRENGTH ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FSGS\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":0.3931,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FSGS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FSGS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2577616183","title":"Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2577616183","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577616183?lang=en_us&edition=fundamental","pubTime":"2025-10-22 20:00","pubTimestamp":1761134400,"startTime":"0","endTime":"0","summary":"BRISBANE, Calif., Oct.  22, 2025  (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/22/3171023/0/en/Vera-Therapeutics-to-Host-an-Investor-Call-and-Webcast-to-Provide-an-ORIGIN-3-Update-on-November-6-2025-at-4-30-pm-ET.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4209","BK4566","IE00BJJMRX11.SGD","LU0417517546.SGD","BK4581","LU1732799900.SGD","LU1430594728.SGD","LU0256863811.USD","LU0942090050.USD","LU2347655073.USD","LU1585245621.USD","LU2347655156.SGD","LU1035773651.USD","VERA","IE00BJJMRY28.SGD","LU1732800096.USD","BK4561","BK4181","LU1074936037.SGD","LU0726765562.USD","BK4218","BK4534","TACI","IE00B7KXQ091.USD","BK4144","BK4539","FSGS","LU0795875169.SGD","LU0912757837.SGD","LU1244550494.USD","BK4585","LU2279689827.SGD","ET","MCD","BK4610","LU0868494708.USD","IE0004445015.USD","LU2133065610.SGD","IE00BFSS7M15.SGD","LU1718418525.SGD","IE00BJTD4V19.USD","BK4550","LU0795875086.SGD","LU1069347547.HKD","BK4588","HST","LU0868494617.USD","IE00BJTD4N35.SGD","LU1244550221.USD","IE00BFSS8Q28.SGD"],"gpt_icon":0},{"id":"2576272059","title":"Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576272059","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576272059?lang=en_us&edition=fundamental","pubTime":"2025-10-17 21:12","pubTimestamp":1760706720,"startTime":"0","endTime":"0","summary":"BRISBANE, Calif., Oct.  17, 2025  (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treat","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/17/3168657/0/en/Vera-Therapeutics-Announces-ORIGIN-3-Late-Breaking-Abstract-Selected-as-Featured-Oral-Presentation-at-Opening-Plenary-Session-of-ASN-Kidney-Week-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFSS8Q28.SGD","IE00B7KXQ091.USD","MCD","BK4610","LU1430594728.SGD","BK4566","LU1244550494.USD","LU0868494708.USD","LU1718418525.SGD","BK4504","IE00BJJMRY28.SGD","LU0795875169.SGD","LU0912757837.SGD","LU2279689827.SGD","IE00BJTD4V19.USD","BK4209","LU1732799900.SGD","VERA","LU0726765562.USD","LU0795875086.SGD","IE00BJJMRX11.SGD","LU1244550221.USD","LU1244550577.SGD","BK4550","TACI","FSGS","IE00BFSS7M15.SGD","LU0417517546.SGD","BK4539","LU0868494617.USD","LU2347655156.SGD","LU2347655073.USD","BK4534","IE0004445015.USD","LU2133065610.SGD","LU1585245621.USD","LU0256863811.USD","BK4588","LU1074936037.SGD","BK4581","BK4585","IE00BJTD4N35.SGD","LU0942090050.USD","LU1069347547.HKD","LU1732800096.USD","LU1035773651.USD","BK4139"],"gpt_icon":0},{"id":"2571336480","title":"Dimerix's Drug Candidate to Treat Kidney Disease Receives Orphan Drug Designation in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2571336480","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571336480?lang=en_us&edition=fundamental","pubTime":"2025-09-30 07:49","pubTimestamp":1759189755,"startTime":"0","endTime":"0","summary":"Dimerix  said its drug candidate, DMX-200, for the treatment of focal segmental glomerulosclerosis , a serious and rare disease that attacks the kidney, has received Orphan Drug designation in Japan, according to a Tuesday filing with the Australian bourse.Japanese partner FUSO Pharmaceutical Industries has exclusive rights to develop, register, and commercialize DMX-200 to treat FSGS in the Japanese market.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","BK7508","DXB.AU","BK7067","FSGS"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":23,"code":"91000000","status":"200"}]}}